All data are based on the daily closing price as of July 15, 2025
j

Johnson Chemical Pharmaceutical Works

4747.TWO
2.08 USD
-0.03
-1.42%

Overview

Last close
2.08 usd
Market cap
93.65M usd
52 week high
2.76 usd
52 week low
1.95 usd
Target price
N/A usd

Valuation

P/E
32.4468
Forward P/E
N/A
Price/Sales
4.6063
Price/Book Value
1.6131
Enterprise Value
62.79M usd
EV/Revenue
3.0889
EV/EBITDA
13.6983

Key financials

Revenue TTM
20.33M usd
Gross Profit TTM
8.32M usd
EBITDA TTM
4.08M usd
Earnings per Share
0.06 usd
Dividend
0.06 usd
Total assets
59.83M usd
Net debt
N/A usd

About

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded in 1959 and is based in New Taipei City, Taiwan.
  • Symbol
    4747.TWO
  • Exchange
    TWO
  • Isin
    TW0004747001
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. P. H. Huang
  • Headquarter
    New Taipei City
  • Web site
    https://www.jcpjohnson.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top